DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
W•••• H••••• C••••••••• L••
Life Sciences Tools & Servicesgroup grade Aon a schedule nowsponsor not established · possible relationship
Also written as: LLC Type
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
100¢ · 100¢ · 101¢Q4 2025 to Q2 2026
Principal held
at least $30.1M
sum of BDC pieces, a lower bound
Fair value
$30.1M
101c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
1 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Oct 23, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| F••••••• P•••••• C••••• F••• | $30.1M | 101¢ | +1 pts |
Every BDC piece · 3 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| F••••••• P•••••• C••••• F••• | term loan first lien F•••• L••• D••• T••• L••• R•••••••• R••• and S••••• S••• + 4.75% I••••••• R••• 8.39% M•••• | $27.7M | $27.7M 100c | SOFR+475 bp |
| F••••••• P•••••• C••••• F••• | revolver first lien F•••• L••• D••• R•••••••• Credit F••••••• R•••••••• R••• and S••••• S••• + 4.75% I••••••• | $1.7M | $1.7M 101c | SOFR+475 bp |
| F••••••• P•••••• C••••• F••• | delayed draw term loan first lien F•••• L••• D••• D•••••• D••• T••• L••• R•••••••• R••• and S••••• S••• + 4.75% I••••••• R•• | $695,652 | $695,652 105c | SOFR+475 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $27.7M | 100c | SOFR+475 bp | Oct 23, 2028 | 2 |
| first lien revolver first lien | at least $1.7M | 101c | SOFR+475 bp | Oct 23, 2028 | 2 |
| first lien delayed draw term loan first lien | at least $695,652 | 105c | SOFR+475 bp | Oct 23, 2028 | 2 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $30.1M | $30.1M | 101c | 0 |
| Mar 31, 2026 | 2 | $43.7M | $43.5M | 100c | 0 |
| Dec 31, 2025 | 2 | $42.5M | $42.2M | 100c | 0 |
What changed
- New borrower on a BDC scheduleDec 31, 2025
Sponsor
Possible relationship, not established: R•••••• A••••••••• L••, because a company of this name is on the sponsor's portfolio page (confidence 0.7). No deal announcement or filing names it as a party, so it is not shown as this borrower’s sponsor.
- R•••••• A••••••••• L••
- the sponsor's own portfolio page lists a company of this nameestimatedrenovuscapital.com"••• Locked"
Identity
- Group key
- W•••• H••••• C•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Life Sciences Tools & Servicesreportedas one filer wrote it